Moderna (MRNA)
1 big move explained, newest first · Biotech
- Down 17.6%
Moderna falls 18% as strong cancer-vaccine data misses sky-high hopes
Moderna's cancer vaccine worked, but results leaked and confirmed the same day fell short of hopes built into a stock up about 8× this year before the drop.